These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11183451)

  • 1. Effect of anti-infective ophthalmic solutions on corneal cells in vitro.
    Matsumoto S; Stern ME
    Adv Ther; 2000; 17(3):148-51. PubMed ID: 11183451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells.
    Sosa AB; Epstein SP; Asbell PA
    Cornea; 2008 Sep; 27(8):930-4. PubMed ID: 18724156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of topical fluoroquinolones on the pathogenesis of diffuse lamellar keratitis in experimental in vivo studies.
    Mah FS; Romanowski EG; Dhaliwal DK; Yates KA; Gordon YJ
    J Cataract Refract Surg; 2006 Feb; 32(2):264-8. PubMed ID: 16565003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets.
    Miyake T; Ito N; Tajima K; Goto H; Furukawa T
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1035-41. PubMed ID: 22282216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells.
    Scuderi AC; Paladino GM; Marino C; Trombetta F
    Cornea; 2003 Jul; 22(5):468-72. PubMed ID: 12827054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
    Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ
    Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo toxicity of netilmicin and ofloxacin on intact and mechanically damaged eyes of rabbit.
    Marino C; Paladino GM; Scuderi AC; Trombetta F; Mugridge K; Enea V
    Cornea; 2005 Aug; 24(6):710-6. PubMed ID: 16015091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM
    Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children.
    Gross RD; Hoffman RO; Lindsay RN
    Clin Pediatr (Phila); 1997 Aug; 36(8):435-44. PubMed ID: 9272316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of two chondroitin sulfate ophthalmic solutions in the therapy of spontaneous chronic corneal epithelial defects and ulcerative keratitis associated with bullous keratopathy in dogs.
    Ledbetter EC; Munger RJ; Ring RD; Scarlett JM
    Vet Ophthalmol; 2006; 9(2):77-87. PubMed ID: 16497231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity.
    Cutarelli PE; Lass JH; Lazarus HM; Putman SC; Jacobs MR
    Curr Eye Res; 1991 Jun; 10(6):557-63. PubMed ID: 1893771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy.
    Patel GM; Chuang AZ; Kiang E; Ramesh N; Mitra S; Yee RW
    J Cataract Refract Surg; 2000 May; 26(5):690-4. PubMed ID: 10831898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of comet assays under conditions mimicking ocular instillation administration in a three-dimensional reconstructed human corneal epithelial model.
    Tahara H; Sadamoto K; Yamagiwa Y; Nemoto S; Kurata M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):375-383. PubMed ID: 31223032
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells.
    Tsai TH; Chen WL; Hu FR
    Eye (Lond); 2010 May; 24(5):909-17. PubMed ID: 19648900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.
    Prajna NV; George C; Selvaraj S; Lu KL; McDonnell PJ; Srinivasan M
    Cornea; 2001 Mar; 20(2):175-8. PubMed ID: 11248824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topical ciprofloxacin 0.3% and ofloxacin 0.3% on the reduction of bacterial flora on the human conjunctiva.
    Snyder-Perlmutter LS; Katz HR; Melia M
    J Cataract Refract Surg; 2000 Nov; 26(11):1620-5. PubMed ID: 11084269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
    Fukuda M; Inoue A; Sasaki K; Takahashi N
    Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.